SS18-SSX, the oncogenic fusion protein in synovial sarcoma, is a cellular context-dependent epigenetic modifier

PLoS ONE

Volumn 10, Issue 11, 2015, Pages

  Tamaki, Sakura ^a   Fukuta, Makoto ^a,b,c   Sekiguchi, Kazuya ^a,b,d   Jin, Yonghui ^a   Nagata, Sanae ^b   Hayakawa, Kazuo ^a,b,c   Hineno, Sho ^a   Okamoto, Takeshi ^d   Watanabe, Makoto ^b,e   Woltjen, Knut ^b   Ikeya, Makoto ^b   Kato, Tomohisa ^b   Toguchida, Junya ^a,b,d  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^d KYOTO UNIVERSITY   (Japan)

^e SHIMADZU CORPORATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BAF47 PROTEIN; HYBRID PROTEIN; ONCOPROTEIN; PROTEIN SWI; SS18 SSX FUSION PROTEIN; TRANSCRIPTION FACTOR SNF; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; FRIZZLED PROTEIN; FZD10 PROTEIN, HUMAN; HISTONE; NONHISTONE PROTEIN; SMALL INTERFERING RNA; SMARCB1 PROTEIN, HUMAN; SS18-SSX1 FUSION PROTEIN; SWI/SNF RELATED MATRIX ASSOCIATED ACTIN DEPENDENT REGULATOR OF CHROMATIN SUBFAMILY B MEMBER 1; TRANSCRIPTION FACTOR; TRANSCRIPTOME;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; EPIGENETICS; FZD10 GENE; GENE; HISTONE MODIFICATION; HUMAN; HUMAN CELL; MESENCHYMAL STROMA CELL; NEURAL CREST CELL; PLURIPOTENT STEM CELL; SERIAL ANALYSIS OF GENE EXPRESSION; SYNOVIAL SARCOMA; ANTAGONISTS AND INHIBITORS; CELL LINE; CYTOLOGY; GENE LOCUS; GENETIC EPIGENESIS; GENETICS; METABOLISM; NEURAL CREST; PATHOLOGY; RNA INTERFERENCE;

CELL DIFFERENTIATION; CELL LINE; CHROMOSOMAL PROTEINS, NON-HISTONE; DNA-BINDING PROTEINS; EPIGENESIS, GENETIC; FRIZZLED RECEPTORS; GENETIC LOCI; HISTONES; HUMANS; MESENCHYMAL STROMAL CELLS; NEURAL CREST; ONCOGENE PROTEINS, FUSION; PLURIPOTENT STEM CELLS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SARCOMA, SYNOVIAL; SMARCB1 PROTEIN; TRANSCRIPTION FACTORS; TRANSCRIPTOME;

EID: 84956707931     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0142991     Document Type: Article

References (50)

1. Eifert C, Powers RS (2012) From cancer genomes to oncogenic drivers, tumour dependencies and therapeutic targets. Nat Rev Cancer 12: 572-578. PMID: 22739505
2. Aryee MJ, Liu W, Engelmann JC, Nuhn P, Gurel M, Haffner MC, et al. (2013) DNA methylation alterations exhibit intraindividual stability and interindividual heterogeneity in prostate cancer metastases. Sci Transl Med 5: 169ra110. doi: 10.1126/scitranslmed.3005211 PMID: 23345608
3. Sreekantaiah C, Ladanyi M, Rodriguez E, Chaganti RS (1994) Chromosomal aberrations in soft tissue tumors. Relevance to diagnosis, classification, and molecular mechanisms. Am J Pathol 144: 1121-1134. PMID: 8203453
4. Jain S, Xu R, Prieto VG, Lee P (2010) Molecular classification of soft tissue sarcomas and its clinical applications. Int J Clin Exp Pathol 3: 416-428. PMID: 20490332
5. Zucman J, Delattre O, Desmaze C, Epstein AL, Stenman G, Speleman F, et al. (1993) EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts. Nat Genet 4: 341-345. PMID: 8401579
6. Hallor KH, Mertens F, Jin Y, Meis-Kindblom JM, Kindblom LG, Behrendtz M, et al. (2005) Fusion of the EWSR1 and ATF1 genes without expression of the MITF-M transcript in angiomatoid fibrous histiocytoma. Genes Chromosomes Cancer 44: 97-102. PMID: 15884099
7. Kralik JM, Kranewitter W, Boesmueller H, Marschon R, Tschurtschenthaler G, Rumpold H, et al. (2011) Characterization of a newly identified ETV6-NTRK3 fusion transcript in acute myeloid leukemia. Diagn Pathol 6:19. doi: 10.1186/1746-1596-6-19 PMID: 21401966
8. Knezevich SR, McFadden DE, Tao W, Lim JF, Sorensen PH (1998) A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma. Nat Genet 18: 184-187. PMID: 9462753
9. Ladanyi M, Antonescu CR, Leung DH, Woodruff JM, Kawai A, Healey JH, et al. (2002) Impact of SYTSSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients. Cancer Res 62: 135-140. PMID: 11782370
10. Clark J, Rocques PJ, Crew AJ, Gill S, Shipley J, Chan AM, et al. (1994) Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma. Nat Genet 7: 502-508. PMID: 7951320
11. Brodin B, Haslam K, Yang K, Bartolazzi A, Xie Y, Starborg M, et al. (2001) Cloning and characterization of spliced fusion transcript variants of synovial sarcoma: SYT/SSX4, SYT/SSX4v, and SYT/SSX2v. Possible regulatory role of the fusion gene product in wild type SYT expression. Gene 268: 173-182. PMID: 11368913
12. Nagai M, Tanaka S, Tsuda M, Endo S, Kato H, Sonobe H, et al. (2001) Analysis of transforming activity of human synovial sarcoma-associated chimeric protein SYT-SSX1 bound to chromatin remodeling factor hBRM/hSNF2 alpha. Proc Natl Acad Sci U S A 98: 3843-3848. PMID: 11274403
13. Haldar M, Hancock JD, Coffin CM, Lessnick SL, Capecchi MR (2007) A conditional mouse model of synovial sarcoma: insights into a myogenic origin. Cancer Cell 11: 375-388. PMID: 17418413
14. Thaete C, Brett D, Monaghan P, Whitehouse S, Rennie G, Rayner E, et al. (1999) Functional domains of the SYT and SYT-SSX synovial sarcoma translocation proteins and co-localization with the SNF protein BRM in the nucleus. Hum Mol Genet 8: 585-591. PMID: 10072425
15. Lim FL, Soulez M, Koczan D, Thiesen HJ, Knight JC (1998) A KRAB-related domain and a novel transcription repression domain in proteins encoded by SSX genes that are disrupted in human sarcomas. Oncogene 17: 2013-2018. PMID: 9788446
16. Kato H, Tjernberg A, Zhang W, Krutchinsky AN, An W, Takeuchi T, et al. (2002) SYT associates with human SNF/SWI complexes and the C-terminal region of its fusion partner SSX1 targets histones. J Biol Chem 277: 5498-5505. PMID: 11734557
17. Su L, Sampaio AV, Jones KB, Pacheco M, Goytain A, Lin S, et al. (2012) Deconstruction of the SS18-SSX fusion oncoprotein complex: insights into disease etiology and therapeutics. Cancer Cell 21: 333-347. doi: 10.1016/j.ccr.2012.01.010 PMID: 22439931
18. Kadoch C, Crabtree GR (2013) Reversible disruption of mSWI/SNF (BAF) complexes by the SS18-SSX oncogenic fusion in synovial sarcoma. Cell 153: 71-85. doi: 10.1016/j.cell.2013.02.036 PMID: 23540691
19. Garcia CB, Shaffer CM, Eid JE (2012) Genome-wide recruitment to Polycomb-modified chromatin and activity regulation of the synovial sarcoma oncogene SYT-SSX2. BMC Genomics 13: 189. PMID: 22594313
20. Nagayama S, Katagiri T, Tsunoda T, Hosaka T, Nakashima Y, Araki N, et al. (2002) Genome-wide analysis of gene expression in synovial sarcomas using a cDNA microarray. Cancer Res 62: 5859-5866. PMID: 12384549
21. Le Douarin NM, Dupin E (2003) Multipotentiality of the neural crest. Curr Opin Genet Dev 13: 529-536. PMID: 14550420
22. Suehara Y, Kondo T, Fujii K, Hasegawa T, Kawai A, Seki K, et al. (2006) Proteomic signatures corresponding to histological classification and grading of soft-tissue sarcomas. Proteomics 6: 4402-4409. PMID: 16807943
23. Yamada K, Ohno T, Aoki H, Semi K, Watanabe A, Moritake H, et al. (2013) EWS/ATF1 expression induces sarcomas from neural crest-derived cells in mice. J Clin Invest 123: 600-610. doi: 10.1172/JCI63572 PMID: 23281395
24. Nagayama S, Fukukawa C, Katagiri T, Okamoto T, Aoyama T, Oyaizu N, et al. (2005) Therapeutic potential of antibodies against FZD 10, a cell-surface protein, for synovial sarcomas. Oncogene 24: 6201-6212. PMID: 16007199
25. Hayakawa K, Ikeya M, Fukuta M, Woltjen K, Tamaki S, Takahara N, et al. (2013) Identification of target genes of synovial sarcoma-associated fusion oncoprotein using human pluripotent stem cells. Biochem Biophys Res Commun 432: 713-719. doi: 10.1016/j.bbrc.2013.01.003 PMID: 23313505
26. Kohno Y, Okamoto T, Ishibe T, Nagayama S, Shima Y, Nishijo K, et al. (2006) Expression of claudin7 is tightly associated with epithelial structures in synovial sarcomas and regulated by an Ets family transcription factor, ELF3. J Biol Chem 281: 38941-38950. PMID: 17060315
27. Woltjen K, Michael IP, Mohseni P, Desai R, Mileikovsky M, Hamalainen R, et al. (2009) piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 458: 766-770. doi: 10.1038/nature07863 PMID: 19252478
28. Fukuta M, Nakai Y, Kirino K, Nakagawa M, Sekiguchi K, Nagata S, et al. (2014) Derivation of Mesenchymal Stromal Cells from Pluripotent Stem Cells through a Neural Crest Lineage using Small Molecule Compounds with Defined Media. PLOS One 9: e112291. doi: 10.1371/journal.pone.0112291 PMID: 25464501
29. Kajita Y, Kato T Jr., Tamaki S, Furu M, Takahashi R, Nagayama S, et al. (2013) The transcription factor Sp3 regulates the expression of a metastasis-related marker of sarcoma, actin filament-associated protein 1-like 1 (AFAP1L1). PLOS One 8: e49709. doi: 10.1371/journal.pone.0049709 PMID: 23326307
30. Aoyama T, Okamoto T, Fukiage K, Otsuka S, Furu M, Ito K, et al. (2010) Histone modifiers, YY1 and p300, regulate the expression of cartilage-specific gene, chondromodulin-I, in mesenchymal stem cells. J Biol Chem 285: 29842-29850. doi: 10.1074/jbc.M110.116319 PMID: 20663886
31. Jin Y, Elalaf H, Watanabe M, Tamaki S, Hineno S, Matsunaga K, et al. (2015) Mutant IDH1 Dysregulates the Differentiation of Mesenchymal Stem Cells in Association with Gene-Specific Histone Modifications to Cartilage-and Bone-Related Genes. PLOS One 10: e0131998. doi: 10.1371/journal.pone. 0131998 PMID: 26161668
32. Umeda K, Oda H, Yan Q, Matthias N, Zhao JG, Davis BR, et al. (2015) Long-Term Expandable SOX9 (+) Chondrogenic Ectomesenchymal Cells from Human Pluripotent Stem Cells. Stem Cell Reports 4: 712-726. doi: 10.1016/j.stemcr.2015.02.012 PMID: 25818812
33. Okamoto T, Aoyama T, Nakayama T, Nakamata T, Hosaka T, Nishijo K, et al. (2002) Clonal heterogeneity in differentiation potential of immortalized human mesenchymal stem cells. Biochem Biophys Res Commun 295: 354-361. PMID: 12150956
34. Lubieniecka JM, de Bruijn DR, Su L, van Dijk AH, Subramanian S, van de Rijn M, et al. (2008) Histone deacetylase inhibitors reverse SS18-SSX-mediated polycomb silencing of the tumor suppressor early growth response 1 in synovial sarcoma. Cancer Res 68: 4303-4310. doi: 10.1158/0008-5472.CAN-08-0092 PMID: 18519690
35. de Bruijn DR, Allander SV, van Dijk AH, Willemse MP, Thijssen J, van Groningen JJ, et al. (2006) The synovial-sarcoma-associated SS18-SSX2 fusion protein induces epigenetic gene (de)regulation. Cancer Res 66: 9474-9482. PMID: 17018603
36. Takenaka S, Naka N, Araki N, Hashimoto N, Ueda T, Yoshioka K, et al. (2010) Downregulation of SS18-SSX1 expression in synovial sarcoma by small interfering RNA enhances the focal adhesion pathway and inhibits anchorage-independent growth in vitro and tumor growth in vivo. Int J Oncol 36: 823-831. PMID: 20198325
37. Ishida M, Miyamoto M, Naitoh S, Tatsuda D, Hasegawa T, Nemoto T, et al. (2007) The SYT-SSX fusion protein down-regulates the cell proliferation regulator COM1 in t(x;18) synovial sarcoma. Mol Cell Biol 27: 1348-1355. PMID: 17101797
38. Garcia CB, Shaffer CM, Alfaro MP, Smith AL, Sun J, Zhao Z, et al. (2012) Reprogramming of mesenchymal stem cells by the synovial sarcoma-associated oncogene SYT-SSX2. Oncogene 31: 2323-2334. doi: 10.1038/onc.2011.418 PMID: 21996728
39. Cironi L, Provero P, Riggi N, Janiszewska M, Suva D, Suva ML, et al. (2009) Epigenetic features of human mesenchymal stem cells determine their permissiveness for induction of relevant transcriptional changes by SYT-SSX1. PLOS One 4: e7904. doi: 10.1371/journal.pone.0007904 PMID: 19936258
40. Cai W, Sun Y, Wang W, Han C, Ouchida M, Xia W, et al. (2011) The effect of SYT-SSX and extracellular signal-regulated kinase (ERK) on cell proliferation in synovial sarcoma. Pathol Oncol Res 17: 357-367. doi: 10.1007/s12253-010-9334-y PMID: 21234732
41. Tschoep K, Kohlmann A, Schlemmer M, Haferlach T, Issels RD (2007) Gene expression profiling in sarcomas. Crit Rev Oncol Hematol 63: 111-124. PMID: 17555981
42. Jones KB, Su L, Jin H, Lenz C, Randall RL, Underhill TM, et al. (2013) SS18-SSX2 and the mitochondrial apoptosis pathway in mouse and human synovial sarcomas. Oncogene 32: 2365-2371, 2375 e2361-2365. doi: 10.1038/onc.2012.247 PMID: 22797074
43. Tsuda M, Watanabe T, Seki T, Kimura T, Sawa H, Minami A, et al. (2005) Induction of p21(WAF1/CIP1) by human synovial sarcoma-associated chimeric oncoprotein SYT-SSX1. Oncogene 24: 7984-7990. PMID: 16103879
44. Davis IJ, Kim JJ, Ozsolak F, Widlund HR, Rozenblatt-Rosen O, Granter SR, et al. (2006) Oncogenic MITF dysregulation in clear cell sarcoma: defining the MiT family of human cancers. Cancer Cell 9: 473-484. PMID: 16766266
45. Kohashi K, Oda Y, Yamamoto H, Tamiya S, Matono H, Iwamoto Y, et al. (2010) Reduced expression of SMARCB1/INI1 protein in synovial sarcoma. Mod Pathol 23: 981-990. doi: 10.1038/modpathol.2010. 71 PMID: 20305614
46. Riccio A (2010) Dynamic epigenetic regulation in neurons: enzymes, stimuli and signaling pathways. Nat Neurosci 13: 1330-1337. doi: 10.1038/nn.2671 PMID: 20975757
47. Ho L, Crabtree GR (2010) Chromatin remodelling during development. Nature 463: 474-484. doi:10. 1038/nature08911 PMID: 20110991
48. Naka N, Takenaka S, Araki N, Miwa T, Hashimoto N, Yoshioka K, et al. (2010) Synovial sarcoma is a stem cell malignancy. Stem Cells 28: 1119-1131. doi: 10.1002/stem.452 PMID: 20518020
49. Ishibe T, Nakayama T, Aoyama T, Nakamura T, Toguchida J (2008) Neuronal differentiation of synovial sarcoma and its therapeutic application. Clin Orthop Relat Res 466: 2147-2155. doi: 10.1007/s11999-008-0343-z PMID: 18563503
50. Haldar M, Hedberg ML, Hockin MF, Capecchi MR (2009) A CreER-based random induction strategy for modeling translocation-associated sarcomas in mice. Cancer Res 69: 3657-3664. doi: 10.1158/0008-5472.CAN-08-4127 PMID: 19351831